NIAGEN BIOSCIENCE, INC. Deferred Tax Liabilities, Gross
NIAGEN BIOSCIENCE, INC. (NAGE) had Deferred Tax Liabilities, Gross of $1.01 million as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-04
- 2025-12-31: Deferred Tax Liabilities, Gross $1.01M.
- 2024-12-31: Deferred Tax Liabilities, Gross $386.00K.
- 2023-12-31: Deferred Tax Liabilities, Gross $358.00K.
- 2022-12-31: Deferred Tax Liabilities, Gross $257.00K.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $1.01M 10-K · filed 2026-03-04 | |
| 2024-12-31 | $386.00K 10-K · filed 2026-03-04 | |
| 2023-12-31 | $358.00K 10-K · filed 2025-03-04 | |
| 2022-12-31 | $257.00K 10-K · filed 2024-03-06 | |
| 2021-12-31 | $445.00K 10-K · filed 2023-03-08 | |
| 2020-12-31 | $253.00K 10-K · filed 2022-03-14 | |
| 2018-12-31 | $137.00K 10-K · filed 2019-03-07 | |
| 2017-12-30 | $144.00K 10-K · filed 2019-03-07 | |
| 2016-12-31 | $399.00K 10-K · filed 2018-03-15 | |
| 2016-01-02 | $413.00K 10-K · filed 2017-03-16 | |
| 2015-01-03 | $143.00K 10-K · filed 2016-03-17 | -$143.00K 10-K · filed 2015-03-19 |
| 2013-12-28 | -$126.00K 10-K · filed 2015-03-19 | |
| 2012-12-29 | -$127.00K 10-K · filed 2014-03-27 | |
| 2011-12-31 | -$167.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |